Correlation Between Eledon Pharmaceuticals and Oramed Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Eledon Pharmaceuticals and Oramed Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eledon Pharmaceuticals and Oramed Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eledon Pharmaceuticals and Oramed Pharmaceuticals, you can compare the effects of market volatilities on Eledon Pharmaceuticals and Oramed Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eledon Pharmaceuticals with a short position of Oramed Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eledon Pharmaceuticals and Oramed Pharmaceuticals.
Diversification Opportunities for Eledon Pharmaceuticals and Oramed Pharmaceuticals
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Eledon and Oramed is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Eledon Pharmaceuticals and Oramed Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oramed Pharmaceuticals and Eledon Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eledon Pharmaceuticals are associated (or correlated) with Oramed Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oramed Pharmaceuticals has no effect on the direction of Eledon Pharmaceuticals i.e., Eledon Pharmaceuticals and Oramed Pharmaceuticals go up and down completely randomly.
Pair Corralation between Eledon Pharmaceuticals and Oramed Pharmaceuticals
Given the investment horizon of 90 days Eledon Pharmaceuticals is expected to under-perform the Oramed Pharmaceuticals. In addition to that, Eledon Pharmaceuticals is 1.96 times more volatile than Oramed Pharmaceuticals. It trades about -0.02 of its total potential returns per unit of risk. Oramed Pharmaceuticals is currently generating about -0.01 per unit of volatility. If you would invest 239.00 in Oramed Pharmaceuticals on September 3, 2024 and sell it today you would lose (2.00) from holding Oramed Pharmaceuticals or give up 0.84% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Eledon Pharmaceuticals vs. Oramed Pharmaceuticals
Performance |
| Timeline |
| Eledon Pharmaceuticals |
| Oramed Pharmaceuticals |
Eledon Pharmaceuticals and Oramed Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eledon Pharmaceuticals and Oramed Pharmaceuticals
The main advantage of trading using opposite Eledon Pharmaceuticals and Oramed Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eledon Pharmaceuticals position performs unexpectedly, Oramed Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oramed Pharmaceuticals will offset losses from the drop in Oramed Pharmaceuticals' long position.| Eledon Pharmaceuticals vs. DiaMedica Therapeutics | Eledon Pharmaceuticals vs. Lyra Therapeutics | Eledon Pharmaceuticals vs. Centessa Pharmaceuticals PLC |
| Oramed Pharmaceuticals vs. Protalix Biotherapeutics | Oramed Pharmaceuticals vs. Corvus Pharmaceuticals | Oramed Pharmaceuticals vs. Aldeyra | Oramed Pharmaceuticals vs. Checkpoint Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |